-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Minrad, Inc. to Piramal Critical Care, Inc. The sponsor's mailing address will also be changed.
DATES:
This rule is effective April 20, 2010.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8307, e-mail: david.newkirk@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Minrad, Inc., 836 Main St., 2d floor, Buffalo, NY 14202 has informed FDA that it has changed its name and address to Piramal Critical Care, Inc., 3950 Schelden Circle, Bethlehem, PA 18017. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c) to reflect this change.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because Start Printed Page 20523it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects in 21 CFR Part 510
- Administrative practice and procedure
- Animal drugs
- Labeling
- Reporting and recordkeeping requirements
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:
End Amendment Part Start PartPART 510—NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 510 continues to read as follows:
End Amendment Part Start Amendment Part2. In § 510.600, in the table in paragraph (c)(1), remove the entry for “Minrad, Inc.” and alphabetically add a new entry for “Piramal Critical Care, Inc.”; and in the table in paragraph (c)(2), revise the entry for “060307” to read as follows:
End Amendment PartNames, addresses, and drug labeler codes of sponsors of approved applications.(c) * * *
(1) * * *
Firm name and address Drug labeler code * * * * * Piramal Critical Care, Inc., 3950 Schelden Circle, Bethlehem, PA 18017 060307 * * * * * (2) * * *
Drug labeler code Firm name and address * * * * * 060307 Piramal Critical Care, Inc., 3950 Schelden Circle, Bethlehem, PA 18017 * * * * * Dated: April 15, 2010.
Elizabeth Rettie,
Deputy Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 2010-9045 Filed 4-19-10; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Effective Date:
- 4/20/2010
- Published:
- 04/20/2010
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2010-9045
- Dates:
- This rule is effective April 20, 2010.
- Pages:
- 20522-20523 (2 pages)
- Docket Numbers:
- Docket No. FDA-2010-N-0002
- Topics:
- Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements
- PDF File:
- 2010-9045.pdf
- CFR: (1)
- 21 CFR 510.600